hoe 33342 and nicotine
hoe 33342 has been researched along with nicotine in 5 studies
Research
Studies (5)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Checchi, L; Ciapetti, G; Monaco, G; Ori, G | 1 |
| Argentin, G; Cicchetti, R | 1 |
| Jandová, K; Langmeier, M; Milotová, M; Pokorný, J; Riljak, V | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Artursson, P; Haglund, U; Karlgren, M; Kimoto, E; Lai, Y; Norinder, U; Vildhede, A; Wisniewski, JR | 1 |
Other Studies
5 other study(ies) available for hoe 33342 and nicotine
| Article | Year |
|---|---|
The effects of nicotine and age on replication and viability of human gingival fibroblasts in vitro.
Topics: Adult; Aging; Benzimidazoles; Cell Division; Cell Line; Cell Survival; Cells, Cultured; Coloring Agents; DNA; Female; Fibroblasts; Fluorescent Dyes; Gingiva; Humans; Male; Neutral Red; Nicotine; Smoking | 1999 |
Genotoxic and antiapoptotic effect of nicotine on human gingival fibroblasts.
Topics: Acetylcysteine; Apoptosis; Benzimidazoles; Catalase; Cell Culture Techniques; Cell Division; Cell Survival; DNA Fragmentation; Dose-Response Relationship, Drug; Fibroblasts; Fluoresceins; Fluorescence; Fluorescent Dyes; Gingiva; Humans; Micronuclei, Chromosome-Defective; Micronucleus Tests; Nicotine; Reactive Oxygen Species; Staurosporine | 2004 |
Morphological changes in the hippocampus following nicotine and kainic acid administration.
Topics: Animals; Benzimidazoles; Excitatory Amino Acid Agonists; Fluoresceins; Fluorescent Dyes; Hippocampus; Injections, Intraperitoneal; Kainic Acid; Male; NADPH Dehydrogenase; Nerve Degeneration; Neurons; Nicotine; Nicotinic Agonists; Organic Chemicals; Rats; Rats, Wistar; Staining and Labeling | 2007 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Classification of inhibitors of hepatic organic anion transporting polypeptides (OATPs): influence of protein expression on drug-drug interactions.
Topics: Atorvastatin; Biological Transport; Drug Interactions; Estradiol; Estrone; HEK293 Cells; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; In Vitro Techniques; Least-Squares Analysis; Liver; Liver-Specific Organic Anion Transporter 1; Models, Molecular; Multivariate Analysis; Organic Anion Transporters; Organic Anion Transporters, Sodium-Independent; Protein Isoforms; Pyrroles; Solute Carrier Organic Anion Transporter Family Member 1B3; Structure-Activity Relationship; Transfection | 2012 |